FAVORABLE OUTCOME FOR ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH EORTC 58951

被引:0
|
作者
Aissaoui, L. [1 ]
Abdennebi, Y. [1 ]
Achour, M. [1 ]
Neji, H. [1 ]
Mansouri, R. [1 ]
Zarrouk, M. [1 ]
Kacem, K. [1 ]
Jeddi, R. [1 ]
Lakhal, R. [1 ]
Abid, H. [1 ]
Ali, Z. [1 ]
Meddeb, B. [1 ]
机构
[1] Aziza Othmana Hosp, Hematol, Tunis, Tunisia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
B1210
引用
收藏
页码:501 / 501
页数:1
相关论文
共 50 条
  • [1] OUTCOME OF CORTICORESITANT PATIENTS TREATED WITH THE PEDIATRIC EORTC 58951 PROTOCOL FOR ACUTE LYMPHOBLASTIC LEUKEMIA
    Medhaffar, M.
    Frikha, I.
    Ajmi, N.
    Hdiji, S.
    Lakhal, A.
    Bellaaj, H.
    Kassar, O.
    Kammoun, L.
    Ben Othmen, T.
    Elloumi, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 493 - 493
  • [2] OUTCOME OF CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED BY THE EORTC 58951 PROTOCOL ABOUT 152 CASES
    Frikha, I.
    Medhaffar, M.
    Hdiji, S.
    Ajmi, N.
    Bellaaj, H.
    Sfaihi, L.
    Kassar, O.
    Kammoun, L.
    Hachicha, M.
    Elloumi, M.
    [J]. HAEMATOLOGICA, 2012, 97 : 492 - 492
  • [3] Epidemiology and response to treatement in child acute lymphoblastic leukemia treated by EORTC 58951
    Bedoui, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 529 - 529
  • [4] FAVORABLE OUTCOME FOR ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED IN THE PEDIATRIC ALL-MB TRIALS IN RUSSIA
    Semochkin, S., V
    Kulikova, S. S.
    Tolstykh, T. N.
    Bobkova, M. M.
    Lukina, A. I.
    Antipova, L. A.
    Lunun, V. V.
    Ivanova, V. L.
    Rumyantsev, A. G.
    [J]. ANNALS OF HEMATOLOGY, 2013, 92 : S25 - S25
  • [5] HIGH RISK CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA GROUP TREATED WITH THE EORTC58951 PROTOCOL: RESULTS AND OUTCOME
    Medhaffar, M.
    [J]. HAEMATOLOGICA, 2015, 100 : 642 - 642
  • [6] Myosteatosis in adolescents and young adults treated for acute lymphoblastic leukemia
    Mueske, Nicole M.
    Mittelman, Steven D.
    Wren, Tishya A. L.
    Gilsanz, Vicente
    Orgel, Etan
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (13) : 3146 - 3153
  • [7] Predictors of methotrexate-induced toxicity and treatment outcome in patients with acute lymphoblastic leukemia treated with EORTC 58951 protocol
    Ben Mahmoud, L.
    Mdhaffar, M.
    Ammar, M.
    Ghozzi, H.
    Ahmed, H.
    Zouheir, S.
    Elloumi, M.
    Zeghal, K.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 71 - 71
  • [8] OUTCOME OF ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC PROTOCOL: MONOCENTRIC STUDY
    Frikha, I.
    Medhaffer, M.
    Hdijji, S.
    Kharrat, R.
    Chaari, M.
    Kassar, O.
    Ghorbel, M.
    Bellaaj, H.
    Ben Amor, I.
    Kallel, F.
    Kallel, C.
    Elloumi, M.
    [J]. HAEMATOLOGICA, 2017, 102 : 664 - 664
  • [9] OUTCOME OF ADOLESCENTS AND YOUNG ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH PEDIATRIC PROTOCOL: 62 CASES
    Medhaffar, M.
    [J]. HAEMATOLOGICA, 2015, 100 : 641 - 642
  • [10] Pediatric randomized trial EORTC CLG 58951: Outcome for adolescent population with acute lymphoblastic leukemia
    Olivier-Gougenheim, Laura
    Arfeuille, Chloe
    Suciu, Stefan
    Sirvent, Nicolas
    Plat, Genevieve
    Ferster, Alina
    de Moerloose, Barbara
    Domenech, Carine
    Uyttebroeck, Anne
    Rohrlich, Pierre-Simon
    Cave, Helene
    Bertrand, Yves
    [J]. HEMATOLOGICAL ONCOLOGY, 2020, 38 (05) : 763 - 772